PMID- 23675868 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20130916 LR - 20211021 IS - 1386-6346 (Print) IS - 1386-6346 (Linking) VI - 43 IP - 9 DP - 2013 Sep TI - Living related liver transplantation in an adult patient with hepatocellular adenoma and carcinoma 13 years after bone marrow transplantation for Fanconi anemia: A case report. PG - 991-8 LID - 10.1111/hepr.12043 [doi] AB - Fanconi anemia (FA) is an inherited bone marrow failure syndrome due to defective DNA inter-strand cross-link repair. Hematopoietic stem cell transplantation (HSCT) is curative for pancytopenia, but may not prevent the development of non-hematological malignancies. We describe a 26-year-old male patient with FA and Marfan syndrome who in 1994 underwent successful HSCT with bone marrow stem cells from his human leukocyte antigen (HLA)-identical sister. In 2006, three lesions in the liver were detected and resected. The three lesions all showed activation of the beta-catenin pathway and were histologically characterized by a highly differentiated steatotic hepatocellular carcinoma (HCC) with remnants of the underlying adenoma from which it arose, a hepatocellular adenoma with foci of well-differentiated HCC, and a cholestatic adenoma. Risk factors for the emergence of HCC included FA itself, the use of androgens for a period of 3 years preceding HSCT and toxicity of the conditioning regimen. Because of the danger of developing additional HCC, liver transplantation was proposed, taking into consideration that immunosuppression would increase the risk of other malignancies. By using part of the liver of the sister, who already acted as bone marrow donor 13 years earlier, immunosuppression could be avoided. Liver transplantation was performed in 2007 without complication. Five years after liver transplantation the patient is doing well. This case is twofold special being the first case reporting FA co-occurring with Marfan syndrome and being the first reported case of FA treated for HCC by liver transplantation from a HLA-identical sibling donor without the use of immunosuppression. CI - (c) 2013 The Japan Society of Hepatology. FAU - Colle, Isabelle AU - Colle I AD - Department of Hepatology and Gastroenterology, Ghent University Hospital, Ghent, Belgium. FAU - Laureys, Genevieve AU - Laureys G FAU - Raevens, Sarah AU - Raevens S FAU - Libbrecht, Louis AU - Libbrecht L FAU - Leroy, Juliaan G AU - Leroy JG FAU - Reyntjens, Koen AU - Reyntjens K FAU - Geerts, Anja AU - Geerts A FAU - Rogiers, Xavier AU - Rogiers X FAU - Troisi, Roberto I AU - Troisi RI FAU - Hoehn, Holger AU - Hoehn H FAU - Schindler, Detlev AU - Schindler D FAU - Hanenberg, Helmut AU - Hanenberg H FAU - De Wilde, Vincent AU - De Wilde V FAU - Van Vlierberghe, Hans AU - Van Vlierberghe H LA - eng GR - R01 CA138237/CA/NCI NIH HHS/United States GR - R01 CA155294/CA/NCI NIH HHS/United States PT - Journal Article DEP - 20130515 PL - Netherlands TA - Hepatol Res JT - Hepatology research : the official journal of the Japan Society of Hepatology JID - 9711801 PMC - PMC3888060 MID - NIHMS540601 OTO - NOTNLM OT - Fanconi anemia OT - bone marrow transplantation OT - hepatocellular carcinoma OT - liver transplantation COIS- Competing interests The authors declare that they have no competing interests. EDAT- 2013/05/17 06:00 MHDA- 2013/05/17 06:01 PMCR- 2014/01/10 CRDT- 2013/05/17 06:00 PHST- 2012/09/15 00:00 [received] PHST- 2012/12/04 00:00 [revised] PHST- 2012/12/07 00:00 [accepted] PHST- 2013/05/17 06:00 [entrez] PHST- 2013/05/17 06:00 [pubmed] PHST- 2013/05/17 06:01 [medline] PHST- 2014/01/10 00:00 [pmc-release] AID - 10.1111/hepr.12043 [doi] PST - ppublish SO - Hepatol Res. 2013 Sep;43(9):991-8. doi: 10.1111/hepr.12043. Epub 2013 May 15.